人乳头瘤病毒早期癌蛋白E6/E7稳定表达细胞系的构建及其对Rab12表达的影响

doi:10.6040/j.issn.1671-7554.0.2018.369

摘要/Abstract

摘要： 目的探究人乳头瘤病毒(HPV)编码的早期癌蛋白E6/E7对小GTP酶蛋白Rab12表达的影响。方法利用逆转录病毒包装系统获得含pBabe-Vector质粒和pBabe-16E7质粒的高滴度病毒颗粒,感染细胞,并用嘌呤霉素筛选获得稳定表达HPV16E7的UMSCC 10A-16E7细胞系,Western blotting检测E7相关蛋白p53和E2F1的表达变化,比较UMSCC 10A-Vector细胞系和UMSCC 10A-16E7细胞系的Rab12蛋白表达水平。用同样方法在HaCaT、RPE1细胞系中进一步验证。用siRNA干扰SiHa、Caski细胞(HPV-16阳性的宫颈癌细胞)中16E6/E7及HeLa细胞(HPV-18阳性的宫颈癌细胞)中18E6/E7的表达,通过Western blotting比较siRNA干扰前后E6和E7相关蛋白(E2F1、p53和Rab12)的表达差异。结果利用逆转录病毒包装系统成功构建稳定表达的细胞系,过表达E6/E7的细胞系中Rab12表达升高,干扰E6/E7的细胞系中Rab12的表达降低。结论 HPV编码的早期癌蛋白E6/E7可调控Rab12的表达。

关键词: Rab12, 人乳头瘤病毒, E6, E7, 逆转录病毒包装系统

Abstract: Objective To explore the impact of early oncoprotein E6/E7, encoded by human papillomavirus(HPV), on the expression of Rab12 protein, a small GTP enzyme protein. Methods The high titer of virus particles, containing pBabe-Vector plasmid and pBabe-16E7 plasmid, were obtained with retroviruses packing system. UMSCC 10A cell line was infected with the virus particles and selected by puromycin to get UMSCC 10A-16E7cell line, which stably expressed HPV16E7. Western blotting was used to detect the expression of E7 associated protein, including p53 and E2F1, to verify the infection. The expression level of Rab12 in UMSCC 10A-Vector and UMSCC 10A-16E7 cell lines was compared. Further verification was conducted in HaCaT and RPE1 cell lines as above. The expression of 16E6/E7 in SiHa cell line and Caski cell line(HPV-16 positive cervical cancer cell line), and the expression of 18E6/E7 in Hela cell line(HPV-18 positive cervical cancer cell line)were interfered by siRNA. Western blotting was used to compare the expression level of E6 and E7 associated protein(E2F1, p53 and Rab12)after the interference. Results These stable-expressed cell lines were successfully built up with retroviruses packaging system. The expression of Rab12 increased in E6/E7 over-expression cells, and decreased in the E6/E7 interfere cells. Conclusion Early oncoprotein E6/E7 coded by HPV can regulate the expression of Rab12.

Key words: Rab12, Human papillomavirus, E6, E7, Retroviruses packaging system

中图分类号:

R737

张文浩,乔立君,郑静怡,陈健行,张魏芳. 人乳头瘤病毒早期癌蛋白E6/E7稳定表达细胞系的构建及其对Rab12表达的影响[J]. 山东大学学报 (医学版), 2018, 56(12): 1-6.

ZHANG Wenhao, QIAO Lijun, ZHENG Jingyi, Jason Chen, ZHANG Weifang. Construction of stable-expressed cell lines of human papillomavirus early oncoprotein E6/E7 and its effect on the expression of Rab12[J]. Journal of Shandong University (Health Sciences), 2018, 56(12): 1-6.

参考文献

[1] Cornetta K, Matheson L, Ballas C. Retroviral vector production in the National Gene Vector Laboratory at Indiana University[J]. Gene Ther, 2005, 12(Suppl 1): S28-35.
[2] Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production[J]. Mol Cell Biol, 1986, 6(8): 2895-2902.
[3] 张继文,杨桂连,王春凤.逆转录病毒载体的应用现状及前景展望[J].生物技术, 2010, 20(4): 89-92. ZHANG Jiwen, YANG Guilian, WANG Chunfeng. Current applied situation of retroviral vector and its prospect[J]. Biotechnology, 2010, 20(4): 89-92.
[4] Harden ME, Munger K. Human papillomavirus molecular biology[J]. Mutat Res Rev Mutat Res, 2017, 772: 3-12. doi: 10.1016/j.mrrev.2016.07.002.
[5] Buck CB, Pastrana DV, Lowy DR, et al. Generation of HPV pseudovirions using transfection and their use in neutralization assays[J]. Methods Mol Med, 2005, 119: 445-462.
[6] Lipovsky A, Popa A, Pimienta G, et al. Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus[J]. Proc Natl Acad Sci U S A, 2013, 110(18): 7452-7457.
[7] Doorbar J. Model systems of human papillomavirus-associated disease[J]. J Pathol, 2016, 238(2): 166-179.
[8] Tang S, Tao M, McCoy JP, et al. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells[J]. Oncogene, 2006, 25(14): 2094-2104.
[9] Yamato K, Fen J, Kobuchi H, et al. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA[J]. Cancer Gene Ther, 2006, 13(3): 234-241.
[10] Lee EH, Ji KY, Kim EM, et al. Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer[J]. Sci Rep, 2017, 7(1): 5759. doi: 10.1038/s41598-017-05977-8.
[11] Doorbar J, Egawa N, Griffin H, et al. Human papillomavirus molecular biology and disease association[J]. Rev Med Virol, 2015, 25(Suppl 1): 2-23.
[12] Dyson N, Howley PM, Münger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product[J]. Science, 1989, 243(4893): 934-937.
[13] 杨丽娟,姚宇峰,严志凌,等. HPV16型E6、E7变异与宫颈癌发生发展的研究进展[J]. 现代肿瘤学, 2016, 11(24): 1829-1832. YANG Lijuan, YAO Yufeng, YAN Zhiling, et al. Systematic review of HPV16 E6/E7 genetic variation and the development of cervical cancer[J]. Modern Oncology, 2016, 11(24): 1829-1832.
[14] Massimi P, Banks L. Repression of p53 transcriptional activity by the HPV E7 proteins[J]. Virology, 1997, 227(1): 255-259.
[15] DiGiuseppe S, Bienkowska-Haba M, Sapp M. Human papillomavirus entry: hiding in a bubble[J]. J Virol, 2016, 90(18): 8032-8035.
[16] Day PM, Thompson CD, Schowalter RM, et al. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection[J]. J Virol, 2013, 87(7): 3862-3870.
[17] 尹洪金,钱桂生,王关嵩.Rab 蛋白研究进展[J].免疫学杂志, 2012, 7(28): 633-636. YIN Hongjin, QIAN Guisheng, WANG Guansong. Recent progresses of Rab GTPases [J]. Immunological Journal, 2012, 7(28): 633-636.
[18] Grosshans B, Ortiz D, Novick P. Rabs and their effectors: achieving specificity in membrane traffic[J]. Proc Natl Acad Sci U S A, 2006, 103(32): 11821-11827.
[19] Yoshida T, Kobayashi T, Itoda M, et al. Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data[J]. Cancer Inform, 2010, 9: 147-161.
[20] Zhang D, Lu C, Ai H. Rab5a is overexpressed in oral cancer and promotes invasion through ERK/MMP signaling[J]. Mol Med Rep, 2017, 16(4): 4569-4576.
[21] An J, Liu Z, Liang Q, et al. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma[J]. Hum Pathol, 2017, 67: 146-151. doi: 10.1016/j.humpath.2017.07.008.
[22] Stenmark H. RabGTPases as coordinators of vesicle traffic[J]. Nat Rev Mol Cell Biol, 2009, 10(8): 513-525.
[23] Olkkonen VM, Dupree P, Killisch I, et al. Molecular cloning and subcellular localization of three GTP-binding proteins of the rab subfamily[J]. J Cell Sci, 1993, 106(Pt 4): 1249-1261.
[24] Iida H, Noda M, Kaneko T, et al. Identification of rab12 as a vesicle-associated small GTPase highly expressed in Sertoli cells of rat testis[J]. Mol Reprod Dev, 2005, 71(2): 178-185.
[25] Matsui T, Itoh T, Fukuda M. Small GTPase Rab12 regulates constitutive degradation of transferrin receptor[J]. Traffic, 2011, 12(10): 1432-1443.
[26] Matsui T, Fukuda M. Small GTPase Rab12 regulates transferrin receptor degradation: implications for a novel membrane trafficking pathway from recycling endosomes to lysosomes[J]. Cell Logist, 2011, 1(4): 155-158.
[27] Matsui T, Fukuda M. Rab12 regulates mTORC1 activity and autophagy through controlling the degradation of amino-acid transporter PAT4[J]. EMBO Rep, 2013, 14(5): 450-457.
[28] Sirohi K, Chalasani ML, Sudhakar C, et al. M98K-OPTN induces transferrin receptor degradation and RAB12-mediated autophagic death in retinal ganglion cells[J]. Autophagy, 2013, 9(4): 510-527.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed